Postbiotics in human health: Possible new functional ingredients?
[Display omitted] •Postbiotics are metabolites or components of the microbiota with effects on the human health.•Postbiotics are SCFAs , enzymes, peptides, teichoic acids, vitamins and plasmalogens.•Postbiotics can be a safe alternative as a treatment for human diseases.•Postbiotics are more stable...
Gespeichert in:
Veröffentlicht in: | Food research international 2020-11, Vol.137, p.109660-109660, Article 109660 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 109660 |
---|---|
container_issue | |
container_start_page | 109660 |
container_title | Food research international |
container_volume | 137 |
creator | Hernández-Granados, María José Franco-Robles, Elena |
description | [Display omitted]
•Postbiotics are metabolites or components of the microbiota with effects on the human health.•Postbiotics are SCFAs , enzymes, peptides, teichoic acids, vitamins and plasmalogens.•Postbiotics can be a safe alternative as a treatment for human diseases.•Postbiotics are more stable and safer for the food industry than probiotics.
The human intestinal microbiota is a set of microorganisms that inhabit the gastrointestinal tract and have a symbiotic relationship with the host. These microorganisms are involved in the regulation of many host metabolic pathways and are related to the host's immune and neurological responses. Probiotic beneficial bacteria and their mechanisms have been extensively studied. However, the health effects of its metabolites or structural components, such as functional ingredients on health have been less explored. Postbiotics can be classified as structural, such as peptides, teichoic acids and plasmalogens. They can also be classified; as well as the metabolites generated by the microbiota; these are short chain fatty acids (SCFAs), vitamins and enzymes. Studies with other types of postbiotics, mainly derived from Lactobacillus, have demonstrated their immunological effects by raising mucin levels and, promoting the development of claudin and occluding. They have also demonstrated decreasing several interleukins of immunological interest. Furthermore, recognized as possible functional ingredients compared to other biotics, they have a longer shelf life and an excellent potential to develop fermented products, being a very good alternative to generate foods with specific health effects. The objective of this review is to describe the characteristics and mechanisms of action of different postbiotics, as well as to present the benefits found in in vitro, clinical trials and in the food industry, proposing them as possible new functional ingredients. |
doi_str_mv | 10.1016/j.foodres.2020.109660 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2464196282</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0963996920306852</els_id><sourcerecordid>2464196282</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-d80bf4fd00ff566506006ba0fb073b479196478a86fd26769a7d47792c75a1b13</originalsourceid><addsrcrecordid>eNqFkE1PwyAYgInRuDn9CZoevXQCbaF4WZbFr2SJHvRMgIJjacsEqvHfS7Pp1YRA8vK8Xw8AlwjOEUTkZjs3zjVehzmGeIwxQuARmKKaFjlFZXUMpilW5IwRNgFnIWwhhKSi7BRMigKPh03B8sWFKK2LVoXM9tlm6ES6tWjj5jZLn8HKVme9_srM0KtoXS_aBL573Vjdx7A4BydGtEFfHN4ZeLu_e1095uvnh6fVcp2rglQxb2ooTWkaCI2pCKkgSdNIAY2EtJAlZYiRktaiJqbBhBImaFNSyrCilUASFTNwva-78-5j0CHyzgal21b02g2B45KUqQaucUKrPap8WsBrw3fedsJ_cwT5aI9v-cEeH-3xvb2Ud3VoMchON39Zv7oSsNgDOi36abXnQSULKrnwWkXeOPtPix_hIYJO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2464196282</pqid></control><display><type>article</type><title>Postbiotics in human health: Possible new functional ingredients?</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Hernández-Granados, María José ; Franco-Robles, Elena</creator><creatorcontrib>Hernández-Granados, María José ; Franco-Robles, Elena</creatorcontrib><description>[Display omitted]
•Postbiotics are metabolites or components of the microbiota with effects on the human health.•Postbiotics are SCFAs , enzymes, peptides, teichoic acids, vitamins and plasmalogens.•Postbiotics can be a safe alternative as a treatment for human diseases.•Postbiotics are more stable and safer for the food industry than probiotics.
The human intestinal microbiota is a set of microorganisms that inhabit the gastrointestinal tract and have a symbiotic relationship with the host. These microorganisms are involved in the regulation of many host metabolic pathways and are related to the host's immune and neurological responses. Probiotic beneficial bacteria and their mechanisms have been extensively studied. However, the health effects of its metabolites or structural components, such as functional ingredients on health have been less explored. Postbiotics can be classified as structural, such as peptides, teichoic acids and plasmalogens. They can also be classified; as well as the metabolites generated by the microbiota; these are short chain fatty acids (SCFAs), vitamins and enzymes. Studies with other types of postbiotics, mainly derived from Lactobacillus, have demonstrated their immunological effects by raising mucin levels and, promoting the development of claudin and occluding. They have also demonstrated decreasing several interleukins of immunological interest. Furthermore, recognized as possible functional ingredients compared to other biotics, they have a longer shelf life and an excellent potential to develop fermented products, being a very good alternative to generate foods with specific health effects. The objective of this review is to describe the characteristics and mechanisms of action of different postbiotics, as well as to present the benefits found in in vitro, clinical trials and in the food industry, proposing them as possible new functional ingredients.</description><identifier>ISSN: 0963-9969</identifier><identifier>EISSN: 1873-7145</identifier><identifier>DOI: 10.1016/j.foodres.2020.109660</identifier><identifier>PMID: 33233239</identifier><language>eng</language><publisher>Canada: Elsevier Ltd</publisher><subject>Bacterial molecules ; Bioactive components ; Fatty Acids, Volatile ; Food industry ; Gastrointestinal Microbiome ; Humans ; Immunomodulation ; Lactobacillus ; Microbiota ; Probiotics ; SCFAs</subject><ispartof>Food research international, 2020-11, Vol.137, p.109660-109660, Article 109660</ispartof><rights>2020 Elsevier Ltd</rights><rights>Copyright © 2020 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-d80bf4fd00ff566506006ba0fb073b479196478a86fd26769a7d47792c75a1b13</citedby><cites>FETCH-LOGICAL-c365t-d80bf4fd00ff566506006ba0fb073b479196478a86fd26769a7d47792c75a1b13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.foodres.2020.109660$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33233239$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hernández-Granados, María José</creatorcontrib><creatorcontrib>Franco-Robles, Elena</creatorcontrib><title>Postbiotics in human health: Possible new functional ingredients?</title><title>Food research international</title><addtitle>Food Res Int</addtitle><description>[Display omitted]
•Postbiotics are metabolites or components of the microbiota with effects on the human health.•Postbiotics are SCFAs , enzymes, peptides, teichoic acids, vitamins and plasmalogens.•Postbiotics can be a safe alternative as a treatment for human diseases.•Postbiotics are more stable and safer for the food industry than probiotics.
The human intestinal microbiota is a set of microorganisms that inhabit the gastrointestinal tract and have a symbiotic relationship with the host. These microorganisms are involved in the regulation of many host metabolic pathways and are related to the host's immune and neurological responses. Probiotic beneficial bacteria and their mechanisms have been extensively studied. However, the health effects of its metabolites or structural components, such as functional ingredients on health have been less explored. Postbiotics can be classified as structural, such as peptides, teichoic acids and plasmalogens. They can also be classified; as well as the metabolites generated by the microbiota; these are short chain fatty acids (SCFAs), vitamins and enzymes. Studies with other types of postbiotics, mainly derived from Lactobacillus, have demonstrated their immunological effects by raising mucin levels and, promoting the development of claudin and occluding. They have also demonstrated decreasing several interleukins of immunological interest. Furthermore, recognized as possible functional ingredients compared to other biotics, they have a longer shelf life and an excellent potential to develop fermented products, being a very good alternative to generate foods with specific health effects. The objective of this review is to describe the characteristics and mechanisms of action of different postbiotics, as well as to present the benefits found in in vitro, clinical trials and in the food industry, proposing them as possible new functional ingredients.</description><subject>Bacterial molecules</subject><subject>Bioactive components</subject><subject>Fatty Acids, Volatile</subject><subject>Food industry</subject><subject>Gastrointestinal Microbiome</subject><subject>Humans</subject><subject>Immunomodulation</subject><subject>Lactobacillus</subject><subject>Microbiota</subject><subject>Probiotics</subject><subject>SCFAs</subject><issn>0963-9969</issn><issn>1873-7145</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1PwyAYgInRuDn9CZoevXQCbaF4WZbFr2SJHvRMgIJjacsEqvHfS7Pp1YRA8vK8Xw8AlwjOEUTkZjs3zjVehzmGeIwxQuARmKKaFjlFZXUMpilW5IwRNgFnIWwhhKSi7BRMigKPh03B8sWFKK2LVoXM9tlm6ES6tWjj5jZLn8HKVme9_srM0KtoXS_aBL573Vjdx7A4BydGtEFfHN4ZeLu_e1095uvnh6fVcp2rglQxb2ooTWkaCI2pCKkgSdNIAY2EtJAlZYiRktaiJqbBhBImaFNSyrCilUASFTNwva-78-5j0CHyzgal21b02g2B45KUqQaucUKrPap8WsBrw3fedsJ_cwT5aI9v-cEeH-3xvb2Ud3VoMchON39Zv7oSsNgDOi36abXnQSULKrnwWkXeOPtPix_hIYJO</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Hernández-Granados, María José</creator><creator>Franco-Robles, Elena</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202011</creationdate><title>Postbiotics in human health: Possible new functional ingredients?</title><author>Hernández-Granados, María José ; Franco-Robles, Elena</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-d80bf4fd00ff566506006ba0fb073b479196478a86fd26769a7d47792c75a1b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Bacterial molecules</topic><topic>Bioactive components</topic><topic>Fatty Acids, Volatile</topic><topic>Food industry</topic><topic>Gastrointestinal Microbiome</topic><topic>Humans</topic><topic>Immunomodulation</topic><topic>Lactobacillus</topic><topic>Microbiota</topic><topic>Probiotics</topic><topic>SCFAs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hernández-Granados, María José</creatorcontrib><creatorcontrib>Franco-Robles, Elena</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Food research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hernández-Granados, María José</au><au>Franco-Robles, Elena</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Postbiotics in human health: Possible new functional ingredients?</atitle><jtitle>Food research international</jtitle><addtitle>Food Res Int</addtitle><date>2020-11</date><risdate>2020</risdate><volume>137</volume><spage>109660</spage><epage>109660</epage><pages>109660-109660</pages><artnum>109660</artnum><issn>0963-9969</issn><eissn>1873-7145</eissn><abstract>[Display omitted]
•Postbiotics are metabolites or components of the microbiota with effects on the human health.•Postbiotics are SCFAs , enzymes, peptides, teichoic acids, vitamins and plasmalogens.•Postbiotics can be a safe alternative as a treatment for human diseases.•Postbiotics are more stable and safer for the food industry than probiotics.
The human intestinal microbiota is a set of microorganisms that inhabit the gastrointestinal tract and have a symbiotic relationship with the host. These microorganisms are involved in the regulation of many host metabolic pathways and are related to the host's immune and neurological responses. Probiotic beneficial bacteria and their mechanisms have been extensively studied. However, the health effects of its metabolites or structural components, such as functional ingredients on health have been less explored. Postbiotics can be classified as structural, such as peptides, teichoic acids and plasmalogens. They can also be classified; as well as the metabolites generated by the microbiota; these are short chain fatty acids (SCFAs), vitamins and enzymes. Studies with other types of postbiotics, mainly derived from Lactobacillus, have demonstrated their immunological effects by raising mucin levels and, promoting the development of claudin and occluding. They have also demonstrated decreasing several interleukins of immunological interest. Furthermore, recognized as possible functional ingredients compared to other biotics, they have a longer shelf life and an excellent potential to develop fermented products, being a very good alternative to generate foods with specific health effects. The objective of this review is to describe the characteristics and mechanisms of action of different postbiotics, as well as to present the benefits found in in vitro, clinical trials and in the food industry, proposing them as possible new functional ingredients.</abstract><cop>Canada</cop><pub>Elsevier Ltd</pub><pmid>33233239</pmid><doi>10.1016/j.foodres.2020.109660</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0963-9969 |
ispartof | Food research international, 2020-11, Vol.137, p.109660-109660, Article 109660 |
issn | 0963-9969 1873-7145 |
language | eng |
recordid | cdi_proquest_miscellaneous_2464196282 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Bacterial molecules Bioactive components Fatty Acids, Volatile Food industry Gastrointestinal Microbiome Humans Immunomodulation Lactobacillus Microbiota Probiotics SCFAs |
title | Postbiotics in human health: Possible new functional ingredients? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T22%3A05%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Postbiotics%20in%20human%20health:%20Possible%20new%20functional%20ingredients?&rft.jtitle=Food%20research%20international&rft.au=Hern%C3%A1ndez-Granados,%20Mar%C3%ADa%20Jos%C3%A9&rft.date=2020-11&rft.volume=137&rft.spage=109660&rft.epage=109660&rft.pages=109660-109660&rft.artnum=109660&rft.issn=0963-9969&rft.eissn=1873-7145&rft_id=info:doi/10.1016/j.foodres.2020.109660&rft_dat=%3Cproquest_cross%3E2464196282%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2464196282&rft_id=info:pmid/33233239&rft_els_id=S0963996920306852&rfr_iscdi=true |